Broad, Functional Claims Made it Hard to Presume Nexus for Commerical Succes
In Teva Pharmaceuticals International GmbH v. Eli Lilly and Company, [2020-1747, 2020-1748, 2020-1750] (August 16, 2021), the Federal Circuit affirmed that Board’s determination that the claims of U.S. Patent Nos. 9,340,614, 9,266,951, and 9,890,210 are unpatentable because they would have … Continue reading Broad, Functional Claims Made it Hard to Presume Nexus for Commerical Succes
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed